SCHEMBL13071965

SCHEMBL13071965

C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC(C)=O)c3csc(N)n3)C2SC1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 7/20 0.80
▸ APEX1 P27695 3/20 0.80
▸ APAF1 O14727 2/20 0.80
▸ LMNA P02545 2/20 0.80
▸ L3MBTL1 Q9Y468 2/20 0.80
▸ TSHR P16473 1/20 0.80
▸ PLCG1 P19174 1/20 0.80
▸ ABCC2 Q92887 1/20 0.80
▸ SIRT5 Q9NXA8 1/20 0.80
▸ MAPT P10636 4/20 0.79
▸ ABCC4 O15439 3/20 0.79
▸ CNR1 P21554 1/20 0.79
▸ CTDSP1 Q9GZU7 1/20 0.79
▸ PSMD14 O00487 1/20 0.79
▸ MMP2 P08253 1/20 0.79
▸ NR1I2 O75469 5/20 0.65
▸ PPARG P37231 2/20 0.65
▸ SLC22A6 Q4U2R8 2/20 0.65
▸ SLC22A8 Q8TCC7 2/20 0.65
▸ SLC22A11 Q9NSA0 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1405938 1.00 TDP1 (0.80) TDP1APEX1APAF1LMNAL3MBTL1
SCHEMBL1405936 1.00 TDP1 (0.80) TDP1APEX1APAF1LMNAL3MBTL1
SCHEMBL1405797 1.00 TDP1 (0.80) TDP1APEX1APAF1LMNAL3MBTL1
SCHEMBL6079725 1.00 TDP1 (0.80) TDP1APEX1APAF1LMNAL3MBTL1
SCHEMBL12809842 1.00 TDP1 (0.80) TDP1APEX1APAF1LMNAL3MBTL1
SCHEMBL6079741 1.00 TDP1 (0.80) TDP1APEX1APAF1LMNAL3MBTL1
Hydrochloric Acid SCHEMBL5515645 0.99 TDP1 (0.82) TDP1APEX1APAF1LMNAL3MBTL1
Hydrochloric Acid SCHEMBL1405969 0.99 TDP1 (0.82) TDP1APEX1APAF1LMNAL3MBTL1
Hydrochloric Acid SCHEMBL3547739 0.99 TDP1 (0.82) TDP1APEX1APAF1LMNAL3MBTL1
Hydrochloric Acid SCHEMBL3547744 0.99 TDP1 (0.82) TDP1APEX1APAF1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825241-B2 Cefdinir intermediate SANDOZ AG (CH) 2010-11-02 — — US disclosed
US-20080081906-A1 CEFDINIR INTERMEDIATE KREMMINGER PETER 2008-04-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081906-A1 CEFDINIR INTERMEDIATE PCMT1, AASDHPPT, SULT1E1 TDP1 4740/4885APEX1 4476/4885APAF1 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback